The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Thursday, August 17, 2023
Wheeler Bio, a clinical contract development and manufacturing organization (CDMO), announced Marc Helouin is appointed Chief Quality and Regulatory ...
read more
Camber Pharmaceuticals is voluntarily recalling lot # E220182 of Atovaquone Oral Suspension, USP 750mg/5mL to the Consumer/User level, due to the ...
read more
Tuesday, January 10, 2023
Spectrum Laboratory Products, Inc. is voluntarily recalling three lots of Epinephrine (L-Adrenaline) USP, a bulk active pharmaceutical ingredient (API...
read more
Tuesday, December 20, 2022
Kite, a Gilead Company and Tmunity Therapeutics (Tmunity), announced that the companies have signed an agreement in which Kite will acquire Tmunity, a...
read more
Wednesday, December 07, 2022
AbbVie and HotSpot Therapeutics, Inc., announced an exclusive worldwide collaboration and option to license agreement for HotSpot's discovery-stage ...
read more
Thursday, November 17, 2022
GE Healthcare’s Pharmaceutical Diagnostics business announced an $80 million investment to increase manufacturing capacity by 30 percent at its Active...
read more
Thursday, November 10, 2022
Celerion is expanding its molecular and cellular capabilities to Good Laboratory Practice/Good Clinical Practice (GLP/GCP) standards to support the ...
read more
Thursday, October 27, 2022
Landmark Bio™, a collective endeavor launched by leaders from academia, the life sciences industry, and world-renowned research hospitals to ...
read more
Sartorius entered a research partnership with The BASE Facility at The University of Queensland (UQ) to improve the manufacturing process of nucleic ...
read more
Valneva announced that the European Commission (EC) approved an amendment to the Advance Purchase Agreement (APA) signed in November 2021 for Valneva’...
read more
Microbiologics, the foremost provider of biomaterials and contract microbiology research services, is pleased to announce the acquisition of ...
read more
Wednesday, November 03, 2021
Arxada, a global specialty chemicals business, and Troy Corporation, a global leader in microbial control solutions and performance additives, today ...
read more
Aptorum Group Limited, a clinical-stage biopharmaceutical company, announces positive progress in respect of: (i) its ongoing Phase I clinical trial ...
read more
Wednesday, March 17, 2021
Codex DNA announced the release of a full-length synthetic genomes for two emerging variants of the SARS-CoV-2 virus.
read more
Thursday, February 25, 2021
INOVIO announced the first participant was dosed in a Phase 1B clinical trial for INO-4500, its DNA vaccine candidate for Lassa fever, in Ghana.
read more